Please login to the form below

Not currently logged in
Email:
Password:

New president at Bayer Healthcare

Dieter Weinand replaces departing Andreas Fibig
Bayer dieter Weinand

Bayer Healthcare has looked to Otsuka Pharmaceuticals to replace its departing president Andreas Fibig.

Dieter Weinand, who is currently president global commercialisation and portfolio management at Otsuka's US subsidiary, will step into his new role at Bayer Healthcare on August 1.

The announcement comes just one week after Weinand's predecessor Fibig announced his intention to leave Bayer Healthcare to join International Flavors & Fragrances as CEO.

Bayer Healthcare's parent group Bayer also announced this week that group CEO Marijn Dekkers will step down from his role at the end of 2016.

In addition to his time at Otsuka, Weinand boasts an impressive CV, serving across multiple regions and therapy areas for Pfizer and Bristole-Myers Squibb.

This includes roles as Pfizer's president for Asia-Pacific and as president for BMS' operations in Latin America and Canada.

6th June 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....